Cover Image

Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Akash Sabarwal, Saba Tabasum, Laxminarayan Rawat, Soumitro Pal
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical and Translational Discovery
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and translational research on cancer of the stomach and gastroesophageal junction: A pathologist's view
by: Christoph Röcken
Published: (2024)

Sticky situation, strategic strike: Targeting neutrophil extracellular trap‐work in cancer
by: Bo Cao, et al.
Published: (2025)

Targeting autophagy: A promising approach for the treatment of breast cancer brain metastases
by: Steffan T. Nawrocki, et al.
Published: (2024)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
by: Fansen Ji, et al.
Published: (2025)

Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
by: Yuichiro Suzukawa, et al.
Published: (2026)

Impacts of immune microenvironment on musculoskeletal health
by: Ren Xu
Published: (2024)

Challenges and advances of immune checkpoint therapy
by: Lingyu Li, et al.
Published: (2024)

Clinical marine biomedicine: An emerging area in clinical and translational medicine
by: Xiaojun Yan, et al.
Published: (2025)

Single‐cell and spatial alterations of neural cells and circuits in clinical and translational medicine
by: William Wang, et al.
Published: (2024)

Clinical and translational mode of single‐cell measurements: An artificial intelligent single cell
by: Xiangdong Wang, et al.
Published: (2024)

Tertiary lymphoid structures: Defining immune subtypes and enabling precision immunotherapy in nasopharyngeal carcinoma
by: Fan Liu, et al.
Published: (2025)

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas
by: Feng Tang, et al.
Published: (2026)

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine
by: Quocdai Vu, et al.
Published: (2026)

High‐fat diet effects on brain mitochondrial complex I activity and protein lipoxidation: implications for translational medicine
by: Vetriselvan Subramaniyan, et al.
Published: (2024)

Beyond the paradox: Cardiac‐specific miR‐106a delivery as a translational turning point for heart failure?
by: Wei‐Wen Lim
Published: (2025)

Host immune collapse in influenza‐associated pulmonary aspergillosis: From barrier dysfunction to metabolic paralysis
by: Liangyu Li, et al.
Published: (2026)

Platelet volume could predict the efficacy of thrombopoietin receptor agonists in the treatment of patients with primary immune thrombocytopenia
by: Bei Xu, et al.
Published: (2025)

Targeting mutated KRAS in the first‐line therapy
by: Hideaki Ijichi
Published: (2024)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
by: Haozhen Liu, et al.
Published: (2024)

Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
by: Swarup Sonar, et al.
Published: (2024)

A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights
by: Anqi Lin, et al.
Published: (2025)

Safety and efficacy of isocitrate dehydrogenase‐1 inhibitor ivosidenib in patients with cholangiocarcinoma
by: Lindsay Wong, et al.
Published: (2026)

Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
by: Jiaqi Liang, et al.
Published: (2025)

Clinical signature of exosomal tetraspanin proteins in cancer
by: Asmit Das, et al.
Published: (2024)

The prospective trajectory of exosomes‐based cancer nanomedicine
by: Divya Mirgh, et al.
Published: (2024)

Investigating the biological effects of socioeconomic adversity in cancer
by: David Füller
Published: (2024)

Nanomedicine: a frontier of the breast cancer treatment
by: Swarup Sonar, et al.
Published: (2024)

Milk exosomes: Harnessing nature's duality for cancer therapy
by: Asmit Das, et al.
Published: (2024)

Clinical trial status of exosomes‐based cancer theranostics
by: Swarup Sonar
Published: (2024)

Engineered cell versus modified exosomes in cancer therapy
by: Rajib Dhar, et al.
Published: (2024)

Signature of click chemistry in exosome modification for cancer therapeutic
by: Nobendu Mukerjee, et al.
Published: (2024)

Plant exosomes: A natural medicine for oral cancer
by: Sidhanti Nyahatkar, et al.
Published: (2024)

Intravital microscopy contribution to cancer: From preclinical to human studies
by: Diogo Moniz‐Garcia, et al.
Published: (2025)

Role of DNA methylation in cancer development and its clinical applications
by: Swarup Sonar, et al.
Published: (2024)

Modified plant‐derived exosomes: Precision medicine in cancer treatment
by: Swastika Maitra, et al.
Published: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
by: Yushan Huang, et al.
Published: (2026)

Translational values of tissue‐resident memory T cells in chronic inflammation and cancer
by: Wanxin Duan, et al.
Published: (2025)

Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer
by: Wei‐Ling Tu, et al.
Published: (2024)

Effects of microRNA on the growth and targeted therapy response on lung cancer
by: Mengchen Zhu, et al.
Published: (2024)

Pharmaceutical company payments to Japanese breast cancer practice guideline authors
by: Anju Murayama, et al.
Published: (2024)